Strategy definition, marketing plan, product positioning, segmentation & targeting, pricing, stakeholder engagement (eg KOL, patients), budget management
Over the course of my 10 years career within Pharmaceutical Marketing , I've had the opportunity either to launch innovative products and work with mature ones, accross different settings (Retail & Hospital) and TAs (eg Cardio, Gastro, Respi, Muskle-Skeletal) at affiliate level.
In my most recent experience, I moved to a Global role, as Business Advisor in the Region Europe Team of Chiesi, where I was responsible for the commercial governance and strategy of Top5 EU countries, thus involved in pivotal processes such as Strategic Planning, Commercial Excellence and Budget-Forecast planning.
From mid 2020, I lead the Global Strategy & Execution of Chiesi Consumer Health Care, with the objective to integrate and internationalize the French VMS company NHCO.
Thanks to the set of skills acquired during my experience, I have been recognized as a person with a strong ability to adapt to different environments, markets and cultures.
Leading the integration and the internationalization of the French VMS company NHCO.
Responsibility in the commercial governance of Top 5 EU (IT, FR, ES, UK, DE)
Leading the Muscle-Skeletal & Gastro portfolio (with class A and C drugs & food supplements) targeting Ortho and Gastro.
Line Extension project lead for Muscle-Skeletal food supplements (Special Care not reimbursed - Darfax & Kalanit).
Leading Pain & Respiratory portfolio (class A & OTC brands), targeting GPs, Ortho and Pharmacies.
Leading the re-launch of the brand Corlentor in the hospital & retail market, with the indications SCAD and Chronic Heart Failure, following the Therapeutic Plan removal.
Marketing activities (eg promotional materials, market research) on Vaccine Prevenar-13, targeting GPs and specialists.